Curative Biosciences Stock Return On Asset
| CBDX Stock | USD 0.0001 0.00 0.00% |
Curative Biosciences fundamentals help investors to digest information that contributes to Curative Biosciences' financial success or failures. It also enables traders to predict the movement of Curative Pink Sheet. The fundamental analysis module provides a way to measure Curative Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Curative Biosciences pink sheet.
Curative |
Curative Biosciences Company Return On Asset Analysis
Curative Biosciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Curative Biosciences Return On Asset | -38.44 |
Most of Curative Biosciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curative Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Curative Biosciences has a Return On Asset of -38.439. This is 339.3% higher than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is notably higher than that of the company.
Curative Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curative Biosciences' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Curative Biosciences could also be used in its relative valuation, which is a method of valuing Curative Biosciences by comparing valuation metrics of similar companies.Curative Biosciences is currently under evaluation in return on asset category among its peers.
Curative Fundamentals
| Return On Asset | -38.44 | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 31.57 M | |||
| Shares Owned By Insiders | 76.24 % | |||
| EBITDA | (50.35 K) | |||
| Net Income | (53.2 K) | |||
| Cash And Equivalents | 982 | |||
| Total Debt | 156.45 K | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (12.8 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 8.19 | |||
| Market Capitalization | 10.56 M | |||
| Total Asset | 2.27 K | |||
| Z Score | -32.4 | |||
| Net Asset | 2.27 K |
About Curative Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Curative Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curative Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curative Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.